XyloCor Therapeutics has closed a $67.5 million Series B round to fund mid-stage development of its cardiac gene therapy.
Two years ago, the biotech said …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Researchers reviewed studies on dietary impacts of GLP-1 and GIP/GLP-1 receptor agonists in obesity and T2D patients, finding significant caloric reduction but limited evaluation of
What You Should Know: – Jerusalem-based Salignostics, a company specializing in rapid tests using saliva samples, has joined forces with ARC Innovation, the innovation arm
Twigstats reveals ancient migrations in Europe, enhancing genomic analysis and uncovering genetic shifts from 500 BCE to 1000 CE with unprecedented precision.